(Date:10/10/2008)...n could lessen long-term side effects, study finds...- Using chemotherapy alone, and delaying or avoidi...ing children with inoperable or progressive low-gr...itutional study. , Low-grade glioma is the most... performed, the survival rate for patients is 95 p...
(Date:10/10/2008)...onoring excellence in the implementation of electr...tion and Management Systems Society (HIMSS) announ...e Organizational, Ambulatory and Community Health ... Chicago, IL (PRWEB) October 10, 2008 -- Honoring...alth records (EHRs), the Healthcare Information a...
(Date:10/10/2008)...Center (BMC) has received a $5,807,469 grant over ...IA) to fund the Boston Claude D. Pepper Older Amer...one of only 11 Pepper Centers in the country. , ... Center Program was established in honor of Claude...ring his five decades of public service, Pepper wa...
(Date:10/10/2008)...PRNewswire/ -- The Mobile Massage Team, (http://ww...n-site seated massage,services for corporate welln...irs, announced today that it is expanding its serv...reater Philadelphia metropolitan region., "We are...r on-site,seated, massage programs and services t...
Breaking Medicine News(10 mins):Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Boston Medical Center receives $5.8m grant 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmeti.../- MatTek Corp. today announced,that ...lti-laboratory,"catch-up" validation study on MatT.... The test results demonstrated the required sensi...as a validated alternative to animal,testing for d...
(Date:10/8/2008)... Cornell University Food Scientists Expand ...xidant Activity Assay, PORTLAND, Maine, Oct. 8 /P...advanced today with the release of results from a ...dozen other commonly consumed,fruits like apples, ...d,test using the Cellular Antioxidant Activity (CA...
(Date:10/8/2008)... -- Exploratory study shows clinical improvem...tension (PAH), -- Current treatment options hav...dly progressive and incurable blood vessel disease... for treatment of certain cancers, known to i... to further explore potential of imatinib mesylate...
(Date:10/7/2008)... AUSTIN, Texas, Oct. 7 /- The Te...id,s Medical Center has been selected as one of,on...FDA-approved clinical,trial for a new device to tr...national treatment, training and research center s...rship between St. David,s Medical Center and,Texas...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Hospital for Special Surgery Ranked No 1 by U S News 26 World Report 23781 1Hospital for Special Surgery Ranked No 1 by U S News 26 World Report 23781 2Hospital for Special Surgery Ranked No 1 by U S News 26 World Report 23781 3M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software 3995 1M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software 3995 21 3 of reef building corals face extinction 3994 11 3 of reef building corals face extinction 3994 21 3 of reef building corals face extinction 3994 31 3 of reef building corals face extinction 3994 4NCOA Applauds Senate Passage of Medicare Bill 23773 1NCOA Applauds Senate Passage of Medicare Bill 23773 2..., June 07, 2007 /PRNewswire-FirstCall/ -,Neurochem...ed,subsidiary of Neurochem Inc. , announces that t...d the results of the "Eprodisate,For AA Amyloidosi...l trial in the search for a treatment of AA amyloi...ial for eprodisate,(KIACTA(TM)) demonstrate that t...
...ting zonisamide SR as a novel component in,EMPATIC...2007 /PRNewswire-FirstCall/ -- Orexigen(TM),Therap... on the,treatment of central nervous system disord...ced results from a Phase I trial evaluating,safety...ustained-release (SR) formulation of zonisamide. I...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v
World's first commercially available vacuum assisted biopsy device for MRI.
...asound and MRI-guided vacuum assisted breast biops...ented, FDA-cleared ATEC system for a faster, safer...east biopsy. Its compassionate care at its best fo...: Useful for biopsy and diagnostic excision of bre...
...asound and MRI-guided vacuum assisted breast biops...ented, FDA-cleared ATEC system for a faster, safer...east biopsy. Its compassionate care at its best fo...: Useful for biopsy and diagnostic excision of bre...
Medicine Products: